SLQT (SelectQuote, Inc.) Stock Analysis - Politician Trades

SelectQuote, Inc. (SLQT) is a publicly traded Financial Services sector company. As of May 21, 2026, SLQT trades at $1.10 with a market cap of $186.93M and a P/E ratio of 10.35. SLQT moved +1.46% today. Year to date, SLQT is -25.53%; over the trailing twelve months it is -53.74%. Its 52-week range spans $0.56 to $6.86. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces SLQT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded SLQT stock?

Rallies tracks politician and congressional stock disclosures for SLQT, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

SLQT Key Metrics

Key financial metrics for SLQT
MetricValue
Price$1.10
Market Cap$186.93M
P/E Ratio10.35
EPS$0.10
Dividend Yield0.00%
52-Week High$6.86
52-Week Low$0.56
Volume5
Avg Volume0
Revenue (TTM)$1.64B
Net Income$91.90M
Gross Margin54.23%

Latest SLQT News

Recent SLQT Insider Trades

  • Grant Robert Clay bought 39.37K (~$35.00K) on Feb 11, 2026.
  • Grant Robert Clay bought 39.51K (~$35.01K) on Feb 11, 2026.
  • Grant Robert Clay bought 40.02K (~$35.02K) on Feb 11, 2026.

SLQT Analyst Consensus

3 analysts cover SLQT: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.00.

Common questions about SLQT

Which politicians traded SLQT stock?
Rallies tracks politician and congressional stock disclosures for SLQT, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in SLQT?
Yes. Rallies tracks politician and congressional stock disclosures for SLQT, including reported purchases, sales, dates, owners, and trade amounts when available.
Is SLQT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SLQT. It does not provide personalized investment advice.
SLQT

SLQT